GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study [0.03%]
glucagon样肽-1受体激动剂治疗可增加溃疡性结肠炎患者的临床缓解:一项队列研究
Budoor Alqinai,Swapna Gayam,Jennifer Hadam-Veverka
Budoor Alqinai
Background: Ulcerative colitis (UC) remains associated with significant morbidity despite therapeutic advances. The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on UC disease activity is not well define...
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor [0.03%]
使用小分子RAB27A抑制剂调节溃疡性结肠炎的免疫毒性
Meital Ben-David-Naim,Dan Bijaoui,Naomi Iluz et al.
Meital Ben-David-Naim et al.
Background: Recent evidence has shown that ulcerative colitis patients with increased neutrophil biomarkers are linked to complicated disease and refractory response. In the pathology of colitis, neutrophils are recruited...
Clinical and endoscopic features of checkpoint inhibitor-induced colitis and their association with selective immunosuppressive therapy use [0.03%]
检查点抑制剂引起的结肠炎的临床和内镜特征及其与选择性免疫抑制治疗使用的关联
Myrthe R Naber,Mick J M van Eijs,Jildou S Huitema et al.
Myrthe R Naber et al.
Background and aims: Immune checkpoint-inhibitor (ICI) colitis is a common adverse event that is primarily treated with corticosteroids but may require selective immunosuppressive therapy (SIT). Although endoscopic featur...
Multicenter Study
Inflammatory bowel diseases. 2026 Nov 1;32(11):2118-2128. DOI:10.1093/ibd/izag104 2026
Novel proteomic signatures of stricturing Crohn disease using a treatment-naive cohort [0.03%]
利用未接受治疗的克罗恩病患者队列研究狭窄型克罗恩病的新蛋白标志物
Zishan Liu,Xiaomin Wu,Weidong Huang et al.
Zishan Liu et al.
Background: Crohn disease (CD) is frequently complicated by intestinal strictures, which require early recognition and management. This study aimed to identify biomarkers associated with CD-related strictures by use of se...
Coccidioidomycosis in patients with inflammatory bowel disease receiving advanced therapy: An observational study from an endemic tertiary center [0.03%]
内生地方性三级医疗中心炎症性肠病接受强化治疗患者的球孢子菌病:一项观察性研究
Fares Jamal,Alejandro J Gonzalez,Geoff Thomas et al.
Fares Jamal et al.
Background: Immunosuppression is a recognized risk factor for severe and disseminated coccidioidomycosis; however, data describing outcomes in patients with inflammatory bowel disease (IBD) receiving advanced therapy, inc...
Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysis [0.03%]
激素避孕药不与溃疡性结肠炎复发加重相关:纵向时间依赖性分析
Beatriz Gros,Carlos Frutos,Eduard Brunet et al.
Beatriz Gros et al.
Background and aim: Hormonal contraception (HCT) is widely used among women with ulcerative colitis (UC), yet its impact on disease activity and inflammatory burden remains unclear. We aimed to evaluate the association be...
Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study) [0.03%]
乌司奴单抗治疗炎症性肠病疗效、持久性和安全性的台湾多中心真实世界研究(T-RUST研究)结果
Shih-Hua Lin,Chia-Jung Kuo,Chiao-Hsiung Chuang et al.
Shih-Hua Lin et al.
Background: Real-world data on ustekinumab (UST) in Asian inflammatory bowel disease (IBD) populations remain limited. The T-RUST (Taiwan Multicenter Real-world Ustekinumab Study) study evaluated the effectiveness, durabi...
The role of glucagon-like peptide 1 receptor agonists in the management of patients with inflammatory bowel diseases [0.03%]
肠促胰素受体激动剂在炎症性肠病患者管理中的作用
Poonam Beniwal-Patel,Sami Samaan,Maria T Abreu et al.
Poonam Beniwal-Patel et al.
Obesity is increasingly prevalent among patients with inflammatory bowel diseases (IBD), with more than half of individuals with Crohns disease (CD) or ulcerative colitis (UC) classified as overweight or obese at diagnosis. Beyond body mass...
Beyond calprotectin: where leucine-rich α2-glycoprotein may fit in small bowel Crohn disease monitoring [0.03%]
超越Calprotectin:Leucine-丰富α2-糖蛋白在小肠克罗恩病监测中的作用
Rajsavi Anand,Andres J Yarur
Rajsavi Anand
Multi-modal ensemble learning prediction of anti-TNF treatment response in pediatric patients with Crohn's disease using clinical, radiomic, and deep learning MR enterography features [0.03%]
基于临床、影像组学和深度学习MR肠造影特征的儿童克罗恩病抗TNF治疗反应多模态集成学习预测模型
Hailong Li,Zhixiu Lu,Nicholas Denson et al.
Hailong Li et al.
Background: Anti-tumor necrosis factor (TNF) medical therapy is a major advancement for Crohn's disease (CD) management, yet many patients fail to respond. This study aims to develop and evaluate a multi-modal ensemble mo...